United Health Products
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of United Health Products generated cash of -$2,200,645, which is less than the previous year. Cash used in financing activities reached the amount of $2,285,538 last year. Net change in cash is therefore $82,043.
Cash Flow
| 2014 | -334.83K | 0 | 341.25K |
|---|---|---|---|
| 2015 | -844.03K | 0 | 837.24K |
| 2016 | -473.35K | 0 | 501.23K |
| 2017 | -645.9K | 0 | 806.47K |
| 2018 | -1.27M | 0 | 1.11M |
| 2019 | -1.76M | 0 | 1.75M |
| 2020 | -1.32M | -101.35K | 1.45M |
| 2021 | -828.07K | 0 | 803.80K |
| 2022 | -619.72K | -40.5K | 651.79K |
| 2023 | -2.20M | -2.85K | 2.28M |
UEEC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 13.37K | 21.79K | 46.07K | 16.62K | 31.27K | 189.94K | 29.36K | 1.48K | 8.27K | 1.85K |
Operating activities | ||||||||||
Net income | -2.62M | -1.68M | -30.54M | -15.71M | -6.60M | -6.00M | -934.96K | -535.73K | -2.59M | -2.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.85K | 4.05K | 0 | 0 | 508.18M | 0 | 0 | 0 | 0 | 50K |
Stock-based compensation expense | 462.5K | 483.45K | 27.17M | 12.72M | 3.88M | 0 | 144K | 0 | 1.71M | 1.12M |
| Deferred income tax benefit | 462.5K | 483.45K | 27.17M | 12.72M | 3.88M | 0 | 144K | 0 | 1.71M | 1.12M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | -10.61K | -362.56K | -96.77K | -8.85K | -870 |
Inventories | 1.13K | -34.73K | 25 | 195 | -44.86K | 19.05K | -101.56K | -20.05K | -10.04K | 1.77K |
Accounts payable | 0 | 638.72K | 693.69K | 360.46K | 367.83K | -71.94K | 44.94K | 178.99K | 44.94K | 156.94K |
Cash generated by operating activities | -2.20M | -619.72K | -828.07K | -1.32M | -1.76M | -1.27M | -645.9K | -473.35K | -844.03K | -334.83K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -40.5K | 0 | -101.35K | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.85K | -40.5K | 0 | -101.35K | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 2.30M | 175.88K | 479.80K | 1.13M | 1.25M | 1.41M | 683.97K | 285.1K | 725.05K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -50K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -19.13K | 552.11K | -324K | -325.96K | 0 | -10K | 32.5K | -216.13K | 112.19K | 0 |
Cash used in financing activities | 2.28M | 651.79K | 803.80K | 1.45M | 1.75M | 1.11M | 806.47K | 501.23K | 837.24K | 341.25K |
Net Change In Cash | 82.04K | -8.42K | -24.27K | 29.45K | -14.64K | -158.66K | 160.57K | 27.88K | -6.79K | 6.41K |
Cash at end of period | 95.42K | 13.37K | 21.79K | 46.07K | 16.62K | 31.27K | 189.94K | 29.36K | 1.48K | 8.27K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |